Owens & Minor, Inc. (NYSE:OMI – Get Free Report) CFO Jonathan A. Leon sold 5,282 shares of the stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the transaction, the chief financial officer now owns 130,822 shares of the company’s stock, valued at $1,546,316.04. The trade was a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Owens & Minor Trading Up 0.9 %
Shares of NYSE:OMI opened at $13.31 on Thursday. The company has a market cap of $1.03 billion, a PE ratio of -20.48, a P/E/G ratio of 0.47 and a beta of 0.41. The company’s 50 day moving average is $13.65 and its two-hundred day moving average is $15.09. Owens & Minor, Inc. has a 52 week low of $11.42 and a 52 week high of $28.35. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11.
Owens & Minor (NYSE:OMI – Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The company had revenue of $2.72 billion during the quarter, compared to the consensus estimate of $2.68 billion. During the same period in the previous year, the business earned $0.44 EPS. Owens & Minor’s revenue for the quarter was up 5.0% on a year-over-year basis. Equities analysts predict that Owens & Minor, Inc. will post 1.49 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Owens & Minor
Analysts Set New Price Targets
Several research firms recently weighed in on OMI. StockNews.com downgraded shares of Owens & Minor from a “buy” rating to a “hold” rating in a report on Monday, August 26th. Citigroup dropped their target price on Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Barclays reduced their price target on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. JPMorgan Chase & Co. dropped their price objective on shares of Owens & Minor from $22.00 to $18.00 and set an “underweight” rating for the company in a report on Wednesday, August 21st. Finally, Robert W. Baird cut their target price on shares of Owens & Minor from $19.00 to $14.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 5th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $18.50.
View Our Latest Analysis on OMI
Owens & Minor Company Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Recommended Stories
- Five stocks we like better than Owens & Minor
- How to Buy Cheap Stocks Step by Step
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What does consumer price index measure?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- ETF Screener: Uses and Step-by-Step Guide
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.